Home
Email:
Password:
Forget your password?
Sheldon Dorenfest, CEO of the Dorenfest Group
More podcasts
Thursday, July 2, 2009
Xiamen medical device association formed
Free access
Kangmei to be exclusive raw TCM supplier to Nepstar
Guilin Sanjin Pharma breaks seal on China IPO market after 9-month halt
China too loose with anti-diarrheal antibiotic prescriptions?
Golden Meditech cuts cord bank, will spin-off division for IPO in US
Free access
NeoStem raises additional USD 4 million to expand in China and US
Panel selects H1N1 diagnostic reagents, eight products receive passing grade
Wednesday, July 1, 2009
Abbreviated basic drug list to be released, full version expected in August
Free access
Anhui to pilot hospital reform, private institutions encouraged
National vaccine center breaks ground in Beijing; CNBG, others inject capital
Tuesday, June 30, 2009
German university grants Lanzhou institute rights to cancer screening chip
Sinovac's Panflu approved for wider age group
Three more cities join Yangtze region inter-city medical insurance program
China to stockpile 13m doses of H1N1 vaccine by National Holiday
Beijing Tiantan Biological Products seeks to acquire Chengdu Rongsheng
NCPG replaces board chairman, closer ties with Jizhong Energy implied?
China Pharma Holdings approved for rosuvastatin trials, joins crowded field
Monday, June 29, 2009
Drug procurement and tendering policies further clarified by MOH, SFDA document
Guandong's reforms better executed in non-pilot cities, says report
Free access
Taiwan cross-straits medical tourism hampered by tough visa regulations
Restylane approval adds (and removes) new wrinkle to China cosmetic treatments
Shanghai Fosun Pharmaceutical to raise RMB 1 billion via new share issue
Friday, June 26, 2009
Jiaotong Medical College to create specialized disease centers at affiliates
China & Italy cooperate on thalassemia research
Beijing hospitals psych selves up
Free access
About us
|
Contact us
|
FAQ
|
Feedback
© GB Group limited. All right reserved.
pharmaceutical,china pharmaceutical,pharm,pharmhound,generalbiologic,China drug,Drug discovery,Pharmaceutical market,China Antibody,China preclinical,China clinical trial,China CRO,China API,Matthew Chervenak,China research and development,China hepatitis,China cancer,China diabetes,China oncology,China cardiovascular,China CNS,China disease